Akebia Therapeutics Balance Sheet (2013-2026) | AKBA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	246.99M	207.20M	149.80M	174.56M	143.90M	144.80M	90.47M	57.00M	53.60M	46.53M	42.92M	41.96M	39.50M	34.02M	51.87M	113.40M	137.31M	166.40M	184.84M	162.60M
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)	246.99M	207.20M	149.80M	174.56M	143.90M	144.80M	90.47M	57.00M	53.60M	46.53M	42.92M	41.96M	39.50M	34.02M	51.87M	113.40M	137.31M	166.40M	184.84M	162.60M
Receivables - Net (Quarter)	35.01M	49.69M	51.58M	65.36M	82.00M	23.27M	40.28M	18.73M	19.57M	22.59M	39.29M	26.62M	29.77M	32.17M	34.37M	61.54M	72.81M	66.22M	47.03M	62.54M
Receivables - Other (Quarter)	1.93M	21.41M	4.31M	3.97M	56.63M	1.87M	0.78M		0.53M	0.48M	3.33M	2.69M	1.83M	1.82M		1.57M	5.37M		0.19M	0.10M
Receivables (Quarter)	36.93M	71.10M	55.89M	69.33M	138.63M	25.14M	41.06M	18.73M	20.10M	23.07M	42.62M	29.31M	31.59M	33.99M	34.37M	63.10M	78.18M	66.22M	47.23M	62.64M
Inventory (Quarter)	37.90M	33.69M	36.63M	41.10M	40.23M	45.24M	21.57M	20.41M	20.91M	18.44M	15.69M	25.53M	23.87M	20.49M	16.24M	19.73M	16.71M	18.64M	15.61M	13.00M
Prepaid Assets (Quarter)	11.18M	39.50M	33.14M	24.12M	42.13M	28.94M	17.25M	24.70M	24.40M	22.04M	20.24M	18.83M	7.33M	13.44M	7.32M	7.92M	7.83M	7.03M	3.77M	3.60M
Current Assets (Quarter)	331.08M	330.08M	271.15M	305.14M	308.25M	242.21M	185.18M	120.80M	118.45M	109.60M	118.15M	112.94M	112.10M	100.12M	113.83M	203.78M	234.66M	258.34M	252.96M	243.48M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	7.67M	7.20M	6.75M	6.45M	6.04M	5.62M	5.21M	4.82M	4.42M	4.02M	3.63M	3.27M	2.90M	2.53M	2.20M	1.90M	1.71M	1.47M	1.22M	0.96M
Long-Term Investments (Quarter)
Goodwill (Quarter)	55.10M	55.10M	59.00M	59.04M	59.04M	59.04M	59.04M	59.04M	59.04M	59.04M	59.04M	59.00M	59.00M	59.00M	59.00M	59.00M	59.04M	59.00M	59.00M	59.00M
Intangibles (Quarter)	126.15M	117.14M	108.13M	99.12M	90.11M	81.09M	72.08M	63.07M	54.06M	45.05M	36.04M	27.03M	18.02M	9.01M
Goodwill & Intangibles (Quarter)	181.25M	172.24M	167.13M	158.16M	149.15M	140.14M	131.13M	122.12M	113.11M	104.10M	95.09M	86.03M	77.02M	68.01M	59.00M	59.00M	59.04M	59.00M	59.00M	59.00M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	67.47M	69.60M	50.42M	39.42M	34.95M	25.94M	5.37M	5.24M	3.35M	3.86M	12.42M	11.79M	17.78M	27.13M	37.38M	38.34M	44.19M	40.46M	59.68M	56.57M
Non-Current Assets (Quarter)	280.79M	272.18M	258.20M	236.66M	221.63M	202.04M	170.87M	160.13M	135.26M	125.40M	123.55M	112.53M	108.10M	107.02M	106.84M	106.40M	110.94M	105.82M	123.61M	119.04M
Assets (Quarter)	611.86M	602.27M	529.35M	541.80M	529.88M	444.25M	356.05M	280.93M	253.71M	235.00M	241.70M	225.48M	220.20M	207.14M	220.67M	310.19M	345.60M	364.15M	376.56M	362.52M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	41.98M	28.81M	33.59M	19.47M	24.94M	19.71M	18.02M	12.58M	11.78M	9.04M	14.63M	11.88M	10.11M	13.49M	15.18M	12.66M	11.55M	10.09M	21.18M	8.39M
Payables (Quarter)	41.98M	28.81M	33.59M	19.47M	24.94M	19.71M	18.02M	12.58M	11.78M	9.04M	14.63M	11.88M	10.11M	13.49M	15.18M	12.66M	11.55M	10.09M	21.18M	8.39M
Accumulated Expenses (Quarter)	111.74M	144.70M	109.01M	114.24M	95.00M	92.53M	75.78M	51.08M	56.41M	62.66M	67.73M	53.91M	53.90M	52.22M	63.46M	71.34M	91.61M	106.42M	121.72M	125.06M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)			97.54M	97.85M	98.16M	65.95M	32.00M	24.00M	24.00M	8.00M	17.50M									12.49M
Current Leases (Quarter)
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)	28.47M	43.66M	42.38M	75.80M		44.56M	47.03M	43.30M	43.30M	43.30M	43.30M	43.99M	43.30M			1.24M	5.53M	3.88M	2.68M	4.50M
Total Current Liabilities (Quarter)	165.59M	189.21M	261.05M	258.50M	237.40M	193.13M	129.54M	87.66M	92.18M	79.70M	99.87M	66.49M	107.30M	65.71M	80.91M	91.23M	118.72M	133.38M	162.94M	173.88M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	96.92M	97.23M					34.08M	26.30M	18.49M	34.61M	17.18M	30.14M	38.03M	38.35M	38.69M	46.51M	47.06M	47.64M	48.25M	36.40M
Non-Current Deffered Revenue (Quarter)	16.60M	27.96M	21.47M	65.36M	43.30M	43.30M	43.30M	43.30M	43.30M	43.30M	43.30M	43.30M
Preferred Stock Liabilities (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	27.65M	26.33M	33.70M	32.58M	31.73M	35.29M	28.96M	32.58M	11.48M	10.23M	8.95M	12.71M	6.30M	4.94M	3.55M	7.64M	0.67M
Other Non-Current Liabilities (Quarter)	85.36M	1.93M	84.21M	83.14M	74.61M	83.10M	0.76M	16.77M	0.76M	9.41M		6.77M	2.64M	3.50M	5.20M	5.11M	14.20M	5.20M	2.98M	2.52M
Total Non-Current Liabilities (Quarter)	351.87M	463.19M	371.13M	436.08M	396.34M	352.89M	350.06M	283.28M	279.76M	265.00M	272.29M	245.96M	251.31M	254.04M	264.65M	280.49M	302.17M	317.36M	340.98M	332.62M
Total Liabilities (Quarter)	437.23M	465.12M	455.34M	519.22M	470.95M	435.99M	350.82M	300.05M	280.52M	274.42M	272.29M	252.74M	253.95M	257.54M	269.86M	285.60M	316.37M	322.56M	343.95M	335.14M
Shareholder's Equity
Total Debt (Quarter)	96.92M	97.23M	97.54M	97.85M	98.16M	65.95M	66.08M	50.30M	42.49M	42.61M	34.68M	30.14M	38.03M	38.35M	38.69M	46.51M	47.06M	47.64M	48.25M	48.89M
Common Equity (Quarter)	174.63M	137.15M	74.01M	22.58M	58.94M	8.26M	5.23M	-19.12M	-26.80M	-39.42M	-30.58M	-27.26M	-33.75M	-50.40M	-49.19M	24.58M	29.22M	41.59M	32.61M	27.38M
Shareholder's Equity (Quarter)	174.63M	137.15M	74.01M	22.58M	58.94M	8.26M	5.23M	-19.12M	-26.80M	-39.42M	-30.58M	-27.26M	-33.75M	-50.40M	-49.19M	24.58M	29.22M	41.59M	32.61M	27.38M
Liabilities and Shareholders Equity (Quarter)	611.86M	602.27M	529.35M	541.80M	529.88M	444.25M	356.05M	280.93M	253.71M	235.00M	241.70M	225.48M	220.20M	207.14M	220.67M	310.19M	345.60M	364.15M	376.56M	362.52M
Treasury Shares (Quarter)			0.10M						0.21M	3.67M	0.60M	2.07M	4.31M	4.14M	1.32M	0.74M	6.44M	6.24M	0.33M
Retained Earnings (Quarter)	-1330.13M	-1389.67M	-1462.80M	-1526.31M	-1496.86M	-1550.95M	-1557.03M	-1583.90M	-1595.08M	0.01M	-1608.95M	0.01M	-1635.52M	0.01M	0.01M	0.01M	0.01M	0.01M	-1683.70M	0.01M

Research Tools

Akebia Therapeutics Balance Sheet (2013-2026) | AKBA

Create an account

Sign In

Reset Password